Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

749
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
749
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

561
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
561
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

674
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
674
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

1.9K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
1.9K
Pulmonary Ventilation: Inhalation01:24

Pulmonary Ventilation: Inhalation

4.7K
Pulmonary ventilation is a vital process that ensures the exchange of oxygen and carbon dioxide in the lungs. It refers to the movement of air into and out of the lungs, enabling the body to obtain oxygen and remove waste carbon dioxide. In this article, we will explore the intricacies of pulmonary ventilation, including its underlying principles, mechanisms, and the interplay of pressures within the respiratory system.
Boyle's law becomes particularly pertinent when examining respiratory...
4.7K
Pressure Relationships in Thoracic Cavity01:24

Pressure Relationships in Thoracic Cavity

3.1K
Breathing, otherwise known as pulmonary ventilation, is the process of air movement into and out of the lungs. The main mechanisms propelling pulmonary ventilation are atmospheric pressure (Patm), intra-pulmonary (Ppul ) or intra-alveolar pressure (Palv) within the alveoli, and intrapleural pressure (Pip) within the pleural cavity.
Breathing Mechanisms
Both intra-alveolar and intrapleural pressures rely on specific lung properties. The ability to breathe—allowing air to enter the lungs...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of Eye Diseases and Referral Rates for In-Office Eye Care Across Three SIGHT Studies.

Ophthalmic epidemiology·2025
Same author

Alabama Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (AL-SIGHT): The Impact of Financial Incentives on Health Care Engagement Following Telemedicine-Based Vision Screening.

Current eye research·2025
Same author

Association Between Optic Nerve Head Prelaminar Schisis and Visual Field Progression in Glaucoma.

American journal of ophthalmology·2025
Same author

Social Determinants of Health and Glaucoma Screening and Detection in the SIGHT Studies.

Journal of glaucoma·2024
Same author

A multi-cohort genome-wide association study in African ancestry individuals reveals risk loci for primary open-angle glaucoma.

Cell·2024
Same author

Patient satisfaction with care in an urban tertiary referral academic glaucoma clinic in the US.

Patient preference and adherence·2018
Same journal

Revealing the Hidden Tube: A Simple Laser Solution in a Complex Eye.

Ophthalmology. Glaucoma·2026
Same journal

Focal Epithelial Bullae at the Air-Cornea Interface After Glaucoma Surgery.

Ophthalmology. Glaucoma·2026
Same journal

Effect of intraocular pressure control on visual field progression in the HORIZON trial.

Ophthalmology. Glaucoma·2026
Same journal

Comparing national microinvasive glaucoma surgery procedure rates in response to Medicare and industry payment changes.

Ophthalmology. Glaucoma·2026
Same journal

Standardized Classification System for Dysphotopsia Reporting.

Ophthalmology. Glaucoma·2026
Same journal

The Flip Sides of Interventional Glaucoma.

Ophthalmology. Glaucoma·2026
See all related articles

Related Experiment Video

Updated: Sep 10, 2025

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

3.2K

Intraocular Pressure Matters.

Sasan Moghimi1, Christopher Girkin1, Robert N Weinreb1

  • 1Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, University of California San Diego, La Jolla, California.

Ophthalmology. Glaucoma
|August 26, 2025
PubMed
Summary
This summary is machine-generated.

Effective intraocular pressure (IOP) lowering therapy significantly reduces glaucoma progression. Maintaining stable IOP, with initial reduction goals of 25-35%, is crucial for preventing worsening disease.

Keywords:
FluctuationGlaucomaIntraocular pressure

More Related Videos

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye
09:03

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye

Published on: June 20, 2015

10.1K
A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure
07:37

A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure

Published on: July 14, 2016

15.3K

Related Experiment Videos

Last Updated: Sep 10, 2025

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

3.2K
Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye
09:03

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye

Published on: June 20, 2015

10.1K
A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure
07:37

A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure

Published on: July 14, 2016

15.3K

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Ocular Hypertension Management

Background:

  • Intraocular pressure (IOP) is a critical factor in glaucoma pathogenesis.
  • Glaucomatous progression is linked to IOP levels and fluctuations.
  • Effective IOP-lowering therapy is proven to reduce disease progression.

Purpose of the Study:

  • To highlight the significance of IOP-lowering therapy in managing glaucoma.
  • To emphasize the impact of IOP on optic nerve head (ONH) and retinal tissues.
  • To define target IOP reduction percentages for preventing glaucomatous progression.

Main Methods:

  • Review of evidence from multiple randomized controlled trials (RCTs).
  • Analysis of the relationship between IOP changes and ONH/retinal tissue health.
  • Evaluation of treatment goals for IOP reduction and stabilization.

Main Results:

  • Effective IOP-lowering therapy significantly reduces glaucomatous progression.
  • IOP directly impacts load-bearing connective tissues of the ONH and neurovascular tissues.
  • Initial IOP reduction of 25%-35% is recommended, with higher targets for advanced cases.

Conclusions:

  • IOP-lowering therapy is essential for all stages of glaucoma.
  • Minimizing both diurnal and long-term IOP fluctuations enhances disease control.
  • Achieving and maintaining target IOP levels is key to preventing glaucoma worsening.